The 800 Million Pill

Author: Merrill Goozner
Publisher: Univ of California Press
ISBN: 9780520246706
Size: 36.35 MB
Format: PDF, ePub, Mobi
View: 7510
Download Read Online
Demonstrates that important new drugs are the results of innovative work done at taxpayer-funded universities and at the National Institutes of Health, rather than by pharmaceutical firms who reap the profit and drive up the cost of prescription drugs.

Reasonable Rx

Author: Stan Finkelstein
Publisher: FT Press
ISBN: 9780132703994
Size: 79.77 MB
Format: PDF, ePub, Mobi
View: 1143
Download Read Online
A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.” –Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University “This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.” –Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration “This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.” –Honorable Barney Frank, Congressman from Massachusetts “This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.” –Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177

Global Issues In Pharmaceutical Marketing

Author: Lea Prevel Katsanis
Publisher: Routledge
ISBN: 1136313303
Size: 54.17 MB
Format: PDF, Mobi
View: 5930
Download Read Online
Global Issues in Pharmaceutical Marketing presents a balanced, research-based perspective combined with a practical outlook on the current issues faced by the ethical, biotech, and generic segments of the pharmaceutical industry. It integrates an analytical approach with a global view to examine such issues as market access, digital marketing, emerging markets, branding, and more. The book covers not only the North American and Western European markets, but focuses on non-Western markets, such as Latin America and Asia. Each chapter is written as an individual essay about a given issue, and where relevant, original cases are provided to illustrate how these issues are currently managed by the global industry. This book offers a thoughtful and thorough description of the industry’s current situation and integrates the latest scholarly and industry research from different disciplines in one place for convenient reference. It may be used in the following ways: To stimulate class discussions and inspire new streams of research for academics and graduate students; To introduce the industry to those interested in a career, to orient new industry hires, or to provide experienced practitioners with current research that will enhance their knowledge; To provide an understanding of the industry for those in the healthcare sector, such as physicians, pharmacists, as well as medical and pharmacy students; and To present recent and relevant research for those in government, public or private payers, and public policy environments to facilitate their decision making. This book will prove to be a useful resource and an important source of information for academics and their students, professionals, and policymakers around the world.

Powerful Medicines

Author: Jerry Avorn, M.D.
Publisher: Vintage
ISBN: 0307489752
Size: 75.91 MB
Format: PDF, ePub, Docs
View: 7573
Download Read Online
If you believe that the latest blockbuster medication is worth a premium price over your generic brand, or that doctors have access to all the information they need about a drug’s safety and effectiveness each time they write a prescription, Dr. Jerry Avorn has some sobering news. Drawing on more than twenty-five years of patient care, teaching, and research at Harvard Medical School, he shares his firsthand experience of the wide gap in our knowledge of the effectiveness of one medication as compared to another. In Powerful Medicines, he reminds us that every pill we take represents a delicate compromise between the promise of healing, the risk of side effects, and an increasingly daunting price. The stakes on each front grow higher every year as new drugs with impressive power, worrisome side effects, and troubling costs are introduced. This is a comprehensive behind-the-scenes look at issues that affect everyone: our shortage of data comparing the worth of similar drugs for the same condition; alarming lapses in the detection of lethal side effects; the underuse of life-saving medications; lavish marketing campaigns that influence what doctors prescribe; and the resulting upward spiral of costs that places vital drugs beyond the reach of many Americans. In this engagingly written book, Dr. Avorn asks questions that will interest every consumer: How can a product judged safe by the Food and Drug Administration turn out to have unexpectedly lethal side effects? Why has the nation’s drug bill been growing at nearly 20 percent per year? How can physicians and patients pick the best medication in its class? How do doctors actually make their prescribing decisions, and why do those decisions sometimes go wrong? Why do so many Americans suffer preventable illnesses and deaths that proper drug use could have averted? How can the nation gain control over its escalating drug budget without resorting to rationing or draconian governmental controls? Using clinical case histories taken from his own work as a practitioner, researcher, and advocate, Dr. Avorn demonstrates the impressive power of the well-conceived prescription as well as the debacles that can result when medications are misused. He describes an innovative program that employs the pharmaceutical industry’s own marketing techniques to reduce use of some of the most overprescribed and overpriced products. Powerful Medicines offers timely and practical advice on how the nation can improve its drug-approval process, and how patients can work with doctors to make sure their prescriptions are safe, effective, and as affordable as possible. This is a passionate and provocative call for action as well as a compelling work of clear-headed science.

The Pill Book

Author: Harold M. Silverman
Publisher: Createspace Independent Publishing Platform
ISBN: 9781973929079
Size: 12.29 MB
Format: PDF, ePub
View: 4633
Download Read Online
The Pill BookBy Harold M. Silverman

The Truth About The Drug Companies

Author: Marcia Angell
Publisher: Random House Incorporated
ISBN: 0375760946
Size: 12.96 MB
Format: PDF, ePub, Docs
View: 4318
Download Read Online
A physician and former editor-in-chief of The New England Journal of Medicine provides an explosive critique of the pharmaceutical industry, detailing its dangerous influence on medical research, education, and physicians; exposing the reasons behind the spiraling prescription drug prices; and proposing a program of vital reforms. Reprint.

Compounding Sterile Preparations

Author: E. Clyde Buchanan
Publisher: ASHP
ISBN: 1585284858
Size: 70.86 MB
Format: PDF, Kindle
View: 7414
Download Read Online
The essential sterile compounding reference every pharmacist needs – now with important updates. Compounding Sterile Preparations, Fourth Edition, by E. Clyde Buchanan, Philip J. Schneider, and Ryan A. Forrey, is the most comprehensive and authoritative reference available on sterile compounding. It’s a trusted resource that every pharmacist needs. The newest edition of this publication now includes: Coverage of new USP Chapter on the compounding of hazardous drugs and the existing USP Chapter Updates on regulations related to the Drug Quality and Security Act (DQSA) Seven new chapters and 16 new contributors Appendices offering more extensive reference to online resources Since the last edition published in 2009, much has changed in the world of compounding. Don’t miss out on the latest updated information in this important field.

America Fooled

Author: Timothy Scott
Publisher: Argo Publishing, LLC
ISBN: 9780977307500
Size: 69.98 MB
Format: PDF, Kindle
View: 3657
Download Read Online
Discusses the chemical imbalance theory, the FDA drug approval process and the influence of the pharmaceutical industry, deceptive designs of drug studies, long-term side effects of antidepressants and antipsychotics, and how to achieve good mental health without drugs.

Global Pharmaceuticals

Author: Adriana Petryna
Publisher: Duke University Press
ISBN: 0822387913
Size: 75.63 MB
Format: PDF
View: 3257
Download Read Online
In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or life-saving drugs. Individuals struggle to afford medications; whole populations are neglected, considered too poor to constitute profitable markets for the development and distribution of necessary drugs. The ethnographies brought together in this timely collection analyze both the dynamics of the burgeoning international pharmaceutical trade and the global inequalities that emerge from and are reinforced by market-driven medicine. They demonstrate that questions about who will be treated and who will not filter through every phase of pharmaceutical production, from preclinical research to human testing, marketing, distribution, prescription, and consumption. Whether considering how American drug companies seek to create a market for antidepressants in Japan, how Brazil has created a model HIV/AIDS prevention and treatment program, or how the urban poor in Delhi understand and access healthcare, these essays illuminate the roles of corporations, governments, NGOs, and individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the marketing and availability of medications. Among these are an exploration of how the pharmaceutical industry shapes popular and expert understandings of mental illness in North America and Great Britain. There is also an examination of the agonizing choices facing Ugandan families trying to finance AIDS treatment. Several essays explore the inner workings of the emerging international pharmaceutical regime. One looks at the expanding quest for clinical research subjects; another at the entwining of science and business interests in the Argentine market for psychotropic medications. By bringing the moral calculations involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory for social scientific research. Contributors. Kalman Applbaum, João Biehl, Ranendra K. Das, Veena Das, David Healy, Arthur Kleinman, Betty Kyaddondo, Andrew Lakoff, Anne Lovell, Lotte Meinert, Adriana Petryna, Michael A. Whyte, Susan Reynolds Whyte

Deadly Monopolies

Author: Harriet A. Washington
Publisher: Anchor
ISBN: 0767931238
Size: 41.78 MB
Format: PDF, Docs
View: 353
Download Read Online
The author of the National Book Critics Circle Award-winning Medical Apartheid examines the questionable legal, ethical and social aspects of how the pharmaceutical industry and other powerful interests have received patents for body tissues excised during surgery to further what the author believes to be commercial purposes.